Epidemiology Paper: Tuberculosis Kyle J. Patzner Grand Canyon University: Concepts in Community and Public Health January 12, 2014 Tuberculosis has long been a disease that the human culture has been dealing with which entails significant morbidity and mortality worldwide. With dealing with such a horrific disease over the years, discoveries and evolution on the appropriate ways to contain, diagnose, and challengingly treat the disease has changed. One of the most concerning complications of this worldwide public health issue is the ability for it to quickly spread in high populated areas while becoming ever more resistant to forms of treatment not available in all locations around the world. This is a serious public
Controlling tuberculosis in China Introduction Tuberculosis is a disease of an infectious nature caused by a bacterium known as mycobacterium tuberculosis. The disease spreads through the air. People with the disease can spread it to susceptible people through coughing, sneezing, talking or spitting. It mainly affects the lungs and other parts such as the lymph nodes and kidneys can also be affected. The symptoms for TB are fatigue, coughing, night sweats, weight loss and fever. One third of the population of the world is affected with mycobacterium tuberculosis. The rate of infection is estimated to be one person per second. About 14 million people in the world are infected with active tuberculosis. Drug resistant TB has been recorded to be a serious public health hazard in many countries. Resistant strains have developed making it difficult to treat the disease. TB has caused millions of death mainly in people living with HIV/AIDS ADDIN EN.CITE Ginsberg19981447(Ginsberg, 1998)1447144717Ginsberg, Ann M.The Tuberculosis Epidemic: Scientific Challenges and OpportunitiesPublic Health Reports (1974-)Public Health Reports (1974-)128-13611321998Association of Schools of Public Health00333549http://www.jstor.org/stable/4598234( HYPERLINK l "_ENREF_3" o "Ginsberg, 1998 #1447" Ginsberg, 1998). The World Health Organization came up with the DOTS (Directly Observed, Therapy, Short course) strategy. The approach involves diagnosing cases and treating patients with drugs for about 6-8
Tuberculosis (TB) is an infectious killer worldwide. However, over 95% of TB deaths occur in developing countries (WHO). TB is found to be a curable disease when appropriate medications and treatment are taken. Using the biomedical system is not sufficient to eradicate TB because medical interventions will fail if social determinates aren’t taken into considerations. The biomedical system is a key component in diminishing TB because it allows for diagnosis and control. Social determinants of health play a huge role in shaping one’s health. Three main social determinants that acts as a barrier in curing and preventing TB are income, food insecurity and access to health care.
Tuberculosis, the white plague as used to be called once upon a time is still one of the deadliest bacterial killers affecting almost all parts, all corners of the globe. Though successful anti-tubercular antibiotic regimens and effective vaccine are available for decades and being used in the battle against Koch’s
According to the World Health Organization, tuberculosis (TB) is the number two killer worldwide due to a single infectious agent (WHO, 2017). In 2015, 10.4 million new cases have been identified and 1.8 million people have died from this disease (WHO, 2017). TB is caused by the bacteria Mycobacterium TB, and the majority of TB deaths occur in low and middle-income countries. This disease is curable and preventable, but the lack of access to proper healthcare and medication administration makes it a concern for the most of the world’s population. TB is an airborne disease that can transmit when an infected person coughs, sneezes, spits, laughs, or talks. The majority of TB cases can be cured when the right medications are available and
Tuberculosis is a disease cause by a bacterium that spreads when a person infected with the virus, sneezes, coughs, or even talks and the germs make it into the air for another person to breathe. This bacterium primarily affects the lungs and prevents the proper functioning of the respiratory system. Tuberculosis continues to be a problem in the United States and the problem is even bigger in developing countries such as India where they have seen the growth of MDR-TB cases. The following annotated bibliographies include a variety of peer review journals, a CDC website and the RX for survival video, which addresses the burden of tuberculosis in different parts of the world. The bibliographies also look at the risk factors, prevalence, mortality,
CURRENT POLICY In 1990s, a policy was engineered in New York and the high prevalence of TB (similar to London) was managed and controlled. In 2004, the Department of Health launched a report adopting those action plans, aiming to bring TB under control, based on the following ten points, (Davies, P.
In an era where we consider the improvement of technology as the key to overcoming most a finding of diseases. Tuberculosis disease has been in existence for years; the ancient plague of tuberculosis continues to spread throughout population and countries. Beyond any other infectious disease. “In 2013, 9 million people around the world became sick with TB disease. There were around 1.5 million TB-related deaths worldwide (Kim, Shakow, Castro, Vande, & Farmer, 2015).” With all the technology improvement and drugs we still struggle to manage this deadly disease. Between 18th and19th century tuberculosis spread and reaches its maximal growth in urban and industrial environment of the united states and Europe. During that time in the Western
In 2014, 72% of TB cases were found among people born outside the UK. India, Pakistan and Somalia were the most frequent countries of birth for non-UK born cases, though rates among this group have decreased significantly over the last two years. This decrease in rates is also true in the non-UK born population as a whole. TB remains an illness that is associated with health inequality. People in deprived communities have rates of TB seven times higher than people in the least deprived areas. 34% of cases were found among people not in education or
The Lancet is a high-qualified journal platform of medical sciences in the world. It aims to provide accurate medical researches and reports for professionals and amateurs who are interested in Medicine and the interfering area. This qualitative study explores the efforts Chinese government had made in the disease control programs and the public health systems in order to achieve the global target of tuberculosis control. The outcome of the commitment to tuberculosis control was evaluated through the 2000 national tuberculosis survey conducted throughout China. It’s concluded that China made great progress on the health plan after 1990s but still needs to emphasize on both the health program and the control system to reach their goal for preventing
TB rates and incidences have remained high, with an estimated rate of 9,000,000 new cases of TB worldwide and 1.7 million deaths per year. The incidence rate of TB in Japan is high with 21 cases per 100,000 people in 2010 than many other developed countries, yet the treatments are being provided by a health care provider. (Shimamura et al, 2013). The nation of Brazil occupies the 22nd place in the ranking of the 22 countries with the highest incidence of TB (Ministerio et al 2012). Tuberculosis treatment is very expensive. Direct costs for treatment (including drugs, diagnostics, case management, hospitalization, etc.) of MDR TB averaged $150,000 per case (in 2014 dollars), compared with $17,000 to treat drug-susceptible TB (CDC 2015).
TB Burden in China China is one of the countries in the world that has been most profoundly affected the TB. Approximately 400 million people are infected with TB, and it is the leading cause of death from infectious disease (Center for Global Development, 2015). Every year, 1.4 million people develop active TB. In 1990, 360,000 people in China died from the disease (Center for Global Development, 2015). As a result of this increasing problem, China revitalized its TB program and adopted the DOTS strategy. The implementation of this program has been credited with rapid decline in TB cases.
Individuals originating from countries where tuberculosis is prevalent are at a higher risk of developing active tuberculosis (National Health Service, 2012). Tuberculosis is still highly prevalent in Asia as The World Health Organisation (2012), states “Of the estimated 9 million people
EXECUTIVE SUMMARY India, the second most populous country with over 1.31 billion people, has the highest burden of tuberculosis (TB) in the world, accounting for 20% of the global incidence of TB, and an even higher share of global incidence of multi–drug resistant (MDR) TB. With an estimated 2 million new cases of TB and 5, 00,000 TB-related deaths in India annually, those who got diagnosed with different forms of DR-TB were 35,385 cases but only 20,753 people started on multidrug-resistant TB (MDR-TB) treatment in 2013. The National Tuberculosis Program was launched in 1962, but suffered heavily continuing TB led mortality. Acknowledging this reality, a Revised National Tuberculosis Control Programme (RNTCP) was launched by the Government of India in 1997, however even today it does not comply with World Health Organization (WHO) recommendations.
Introduction Tuberculosis is among the fatal diseases that are spread through the air. It’s contagious, meaning that it spreads from one infected individual to another, and at times it spreads very fast. In addition to being contagious, the disease is an opportunist infection as it takes advantage of those with